The development of laparoscopic liver resection (LLR) has been slow due to technical difficulties. Therefore, LLR has been limited to easily accessible lesions. Recently, this procedure has been well applied to hepatocellular carcinoma. However, until now, the indications for LLR have been tumors in the peripheral portion of the anterolateral segments of the liver (segments II, III, V and VI and the inferior part of IV according to the classification of Couinaud). Due to the growing interest in LLR, there have been many attempts to apply this technique in difficult locations. The lesions in the posterior or superior part of the liver (segments I, VII, VIII and the superior part of IV), which are considered to be poor indications for LLR, have been reported to be successfully operated on by laparoscopic surgery. Accordingly, this laparoscopic approach has become similar to open surgery in many ways. One of the major advancements of LLR is anatomic liver resection including major and minor resection. Laparoscopic mono- and bisegmentectomies have also become possible with growing experience. There are a variety of monosegmentectomies and bisegmentectomies. The common representatives of bisegmentectomies are left lateral sectionectomy, right anterior sectionectomy and right posterior sectionectomy. The common operative types of monosegmentectomies are S4, S5, and S6 monosegmentectomies, etc. Central bi-sectionectomy will also be discussed. The Glissonian approach has been useful for these types of anatomic liver resection. The difficulty of controlling hemorrhage has been overcome by performing meticulous surgical techniques with newly developed instruments, and intraoperative sonography has been used to locate the lesions and guide the resection plane even for deep-seated or invisible lesions. Further accumulation of experience and technical refinements will make theses challenging procedures more reproducible and safer.

1.
Cho JY, Han HS, Yoon YS, Shin SH: Outcomes of laparoscopic liver resection for lesions located in the right side of the liver. Arch Surg 2009;144:25–29.
2.
Yoon YS, Han HS, Cho JY, Ahn KS: Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver. Surg Endosc 2010;24:1630–1677.
3.
Han HS, Cho JY, Yoon YS: Techniques for performing laparoscopic liver resection in various hepatic locations. J Hepatobiliary Pancreat Surg 2009;16:427–432.
4.
Han HS, Yoon YS, Cho JY, Ahn KS: Laparoscopic right hemihepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2010;17:2090–2091.
5.
Yoon YS, Han HS, Choi YS, Jang JY, Suh KS, Kim SW, et al: Total laparoscopic right posterior sectionectomy for hepatocellular carcinoma. J Laparoendosc Adv Surg Tech A 2006;16:274–277.
6.
Gagner M, Rogula T, Selzer D: Laparoscopic liver resection: benefits and controversies. Surg Clin North Am 2004;84:451–462.
7.
Cherqui D, Husson E, Hammoud R, Malassagne B, Stephan F, Bensaid S, et al: Laparoscopic liver resections: a feasibility study in 30 patients. Ann Surg 2000;232:753–762.
8.
Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al: The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 2009;250:825–830.
9.
Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Sa Cunha A, et al: Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740–748.
10.
Yoon YS, Han HS, Shin SH, Cho JY, Min SK, Lee HK: Laparoscopic treatment for intrahepatic duct stones in the era of laparoscopy: laparoscopic intrahepatic duct exploration and laparoscopic hepatectomy. Ann Surg 2009;249:286–291.
11.
Kim SH, Lim SB, Ha YH, Han SS, Park SJ, Choi HS, et al: Laparoscopic-assisted combined colon and liver resection for primary colorectal cancer with synchronous liver metastases: initial experience. World J Surg 2008;32:2701–2706.
12.
Abu Hilal M, Di Fabio F, Abu Salameh M, Pearce NW: Oncological efficiency analysis of laparoscopic liver resection for primary and metastatic cancer: a single-center UK experience. Arch Surg 2012;147:42–48.
13.
Belli G, Fantini C, Belli A, Limongelli P: Laparoscopic liver resection for hepatocellular carcinoma in cirrhosis: long-term outcomes. Dig Surg 2011;28:134–140.
14.
Santambrogio R, Opocher E, Zuin M, Selmi C, Bertolini E, Costa M, et al: Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann Surg Oncol 2009;16:3289–3298.
15.
O’Rourke N, Fielding G: Laparoscopic right hepatectomy: surgical technique. J Gastrointest Surg 2004;8:213–216.
16.
Laurent A, Cherqui D, Lesurtel M, Brunetti F, Tayar C, Fagniez PL: Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. Arch Surg 2003;138:763–769, discussion 769.
17.
Belli G, Fantini C, D’Agostino A, Cioffi L, Langella S, Russolillo N, et al: Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results. Surg Endosc 2007;21:2004–2011.
18.
Kaneko H, Takagi S, Otsuka Y, Tsuchiya M, Tamura A, Katagiri T, et al: Laparoscopic liver resection of hepatocellular carcinoma. Am J Surg 2005;189:190–194.
19.
Belli G, Limongelli P, Fantini C, D’Agostino A, Cioffi L, Belli A, et al: Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2009;96:1041–1048.
20.
Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, et al: Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 2002;236:90–97.
21.
Kaneko H, Takagi S, Shiba T: Laparoscopic partial hepatectomy and left lateral segmentectomy: technique and results of a clinical series. Surgery 1996;120:468–475.
22.
Dulucq JL, Wintringer P, Stabilini C, Berticelli J, Mahajna A: Laparoscopic liver resections: a single center experience. Surg Endosc 2005;19:886–891.
23.
Cho JY, Han HS, Yoon YS, Shin SH: Feasibility of laparoscopic liver resection for tumors located in the posterosuperior segments of the liver, with a special reference to overcoming current limitations on tumor location. Surgery 2008;144:32–38.
24.
Cho JY, Han HS, Yoon YS, Shin SH: Experiences of laparoscopic liver resection including lesions in the posterosuperior segments of the liver. Surg Endosc 2008;22:2344–2349.
25.
Dagher I, Lainas P, Carloni A, Caillard C, Champault A, Smadja C, et al: Laparoscopic liver resection for hepatocellular carcinoma. Surg Endosc 2008;22:372–378.
26.
Kaneko H: Laparoscopic hepatectomy: indications and outcomes. J Hepatobiliary Pancreat Surg 2005;12:438–443.
27.
Nguyen KT, Marsh JW, Tsung A, Steel JJ, Gamblin TC, Geller DA: Comparative benefits of laparoscopic vs open hepatic resection: a critical appraisal. Arch Surg 2011;146:348–356.
28.
Vibert E, Perniceni T, Levard H, Denet C, Shahri NK, Gayet B: Laparoscopic liver resection. Br J Surg 2006;93:67–72.
29.
Simillis C, Constantinides VA, Tekkis PP, Darzi A, Lovegrove R, Jiao L, et al: Laparoscopic versus open hepatic resections for benign and malignant neoplasms – a meta-analysis. Surgery 2007;141:203–211.
30.
Nguyen KT, Gamblin TC, Geller DA: World review of laparoscopic liver resection – 2,804 patients. Ann Surg 2009;250:831–841.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.